• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泌尿微生物组:对膀胱癌发病机制和治疗的影响

The Urinary Microbiome: Implications in Bladder Cancer Pathogenesis and Therapeutics.

作者信息

Bajic Petar, Wolfe Alan J, Gupta Gopal N

机构信息

Department of Urology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL.

Department of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL.

出版信息

Urology. 2019 Apr;126:10-15. doi: 10.1016/j.urology.2018.12.034. Epub 2019 Jan 4.

DOI:10.1016/j.urology.2018.12.034
PMID:30615894
Abstract

Recent investigation has proven that the bladder is not sterile. However, the implications of this finding in the pathophysiology and management of urothelial cell carcinoma have not been fully described. In this review, we summarize the literature relating to the urinary and gastrointestinal microbiomes in the context of urothelial cell carcinoma. The bladder microbiome may relate to urothelial cell carcinoma pathogenesis/progression, act as a noninvasive and modifiable urinary biomarker and have implications in treatment using immunotherapy agents such as intravesical bacillus Calmette-Guerin. Investigators should continue to optimize techniques to characterize this intriguing new area of human health.

摘要

最近的研究已证实膀胱并非无菌。然而,这一发现对尿路上皮细胞癌病理生理学及治疗的影响尚未得到充分描述。在本综述中,我们总结了尿路上皮细胞癌背景下与泌尿及胃肠道微生物群相关的文献。膀胱微生物群可能与尿路上皮细胞癌的发病机制/进展有关,可作为一种非侵入性且可改变的尿液生物标志物,并对使用卡介苗等免疫治疗药物进行治疗有影响。研究人员应继续优化技术,以表征这一引人入胜的人类健康新领域。

相似文献

1
The Urinary Microbiome: Implications in Bladder Cancer Pathogenesis and Therapeutics.泌尿微生物组:对膀胱癌发病机制和治疗的影响
Urology. 2019 Apr;126:10-15. doi: 10.1016/j.urology.2018.12.034. Epub 2019 Jan 4.
2
The Dose-Response Relationship of bacillus Calmette-Guérin and Urothelial Carcinoma Cell Biology.卡介苗与尿路上皮癌细胞生物学的剂量反应关系。
J Urol. 2016 Jun;195(6):1903-10. doi: 10.1016/j.juro.2015.11.073. Epub 2015 Dec 13.
3
Sepsis and granulomatous hepatitis after bacillus Calmette-Guerin intravesical installation.卡介苗膀胱内灌注后发生的脓毒症和肉芽肿性肝炎。
J Infect. 2004 May;48(4):363-4. doi: 10.1016/j.jinf.2004.01.013.
4
Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.卡介苗治疗失败的患者可能是非肌层浸润性膀胱癌,原因可能是泌尿科医生未能检测到上尿路和尿道的尿路上皮癌。
Eur Urol. 2014 Apr;65(4):825-31. doi: 10.1016/j.eururo.2013.09.049. Epub 2013 Oct 9.
5
Reply from Authors re: Tahlita C.M. Zuiverloon, Ellen C. Zwarthoff. Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We Moving Forward? Eur Urol 2016;69:201-2: The Goal: Individualized Bacillus Calmette-Guérin Therapy.
Eur Urol. 2016 Feb;69(2):203. doi: 10.1016/j.eururo.2015.07.031. Epub 2015 Aug 7.
6
Miliary tuberculosis of the lung in a patient treated with bacillus Calmette-Guerin for superficial bladder cancer.一名接受卡介苗治疗浅表性膀胱癌的患者发生了粟粒性肺结核。
J Urol. 1998 May;159(5):1639-40. doi: 10.1097/00005392-199805000-00063.
7
Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.卡介苗维持免疫疗法用于复发性TA、T1期及原位膀胱移行细胞癌:西南肿瘤协作组的一项随机研究
J Urol. 2000 Apr;163(4):1124-9.
8
Bacillus Calmette-Guerin in the treatment of stage T1 grade 3 transitional cell carcinoma of the bladder: long-term results.卡介苗治疗膀胱T1期3级移行细胞癌的长期结果
J Urol. 1995 Dec;154(6):2054-8.
9
Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle-Invasive Bladder Cancer Patients.膀胱内卡介苗联合癌症疫苗可增强非肌层浸润性膀胱癌患者的局部 T 细胞应答。
Clin Cancer Res. 2017 Feb 1;23(3):717-725. doi: 10.1158/1078-0432.CCR-16-1189. Epub 2016 Aug 12.
10
The microbiome of the urinary tract--a role beyond infection.尿路微生物组——超越感染的作用。
Nat Rev Urol. 2015 Feb;12(2):81-90. doi: 10.1038/nrurol.2014.361. Epub 2015 Jan 20.

引用本文的文献

1
The role of Uro-Vaxom in reducing infectious adverse effects and improving outcomes in bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer.优泌康在减少非肌层浸润性膀胱癌卡介苗治疗中的感染性不良反应及改善治疗结果方面的作用。
Investig Clin Urol. 2025 Jul;66(4):344-351. doi: 10.4111/icu.20250060.
2
Microbiome and bladder cancer: the role of probiotics in treatment.微生物群与膀胱癌:益生菌在治疗中的作用
Future Microbiol. 2025 Jan;20(1):73-90. doi: 10.1080/17460913.2024.2414671. Epub 2024 Oct 24.
3
Dysbiosis in Human Urinary Microbiota May Differentiate Patients with a Bladder Cancer.
人类尿液微生物组的失调可能可以区分膀胱癌患者。
Int J Mol Sci. 2024 Sep 21;25(18):10159. doi: 10.3390/ijms251810159.
4
A review of urinary bladder microbiome in patients with bladder cancer and its implications in bladder pathogenesis.膀胱癌患者膀胱微生物组的研究进展及其在膀胱发病机制中的意义。
World J Urol. 2024 Jul 29;42(1):457. doi: 10.1007/s00345-024-05173-0.
5
The Role of Tumor and Host Microbiome on Immunotherapy Response in Urologic Cancers.肿瘤和宿主微生物群在泌尿生殖系统癌症免疫治疗反应中的作用
J Cancer Immunol (Wilmington). 2024;6(1):1-13. doi: 10.33696/cancerimmunol.6.078.
6
Current Trends and Challenges of Microbiome Research in Bladder Cancer.膀胱癌中微生物组研究的现状和挑战。
Curr Oncol Rep. 2024 Mar;26(3):292-298. doi: 10.1007/s11912-024-01508-7. Epub 2024 Feb 20.
7
Is the Urinary and Gut Microbiome Associated With Bladder Cancer?泌尿系统和肠道微生物群与膀胱癌有关联吗?
Clin Med Insights Oncol. 2023 Nov 13;17:11795549231206796. doi: 10.1177/11795549231206796. eCollection 2023.
8
An Overview of the Microbiota of the Human Urinary Tract in Health and Disease: Current Issues and Perspectives.健康与疾病状态下人类泌尿道微生物群概述:当前问题与展望
Life (Basel). 2023 Jun 30;13(7):1486. doi: 10.3390/life13071486.
9
The human microbiome and cancer: a diagnostic and therapeutic perspective.人类微生物组与癌症:诊断与治疗视角。
Cancer Biol Ther. 2023 Dec 31;24(1):2240084. doi: 10.1080/15384047.2023.2240084.
10
From mucosal infection to successful cancer immunotherapy.从黏膜感染到成功的癌症免疫治疗。
Nat Rev Urol. 2023 Nov;20(11):682-700. doi: 10.1038/s41585-023-00784-5. Epub 2023 Jul 11.